200 related articles for article (PubMed ID: 31572002)
1. Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas.
Wei Y; Yi Y; Tao C; Ye W; Zhao W
Cancer Manag Res; 2019; 11():8475-8486. PubMed ID: 31572002
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.
Jung SK; Kim KA; Ha SY; Lee HK; Kim YD; Lee BH; Paik WH; Kim JW; Bae WK; Kim NH; Lee JS; Jwa YJ
Clin Mol Hepatol; 2015 Mar; 21(1):41-8. PubMed ID: 25834801
[TBL] [Abstract][Full Text] [Related]
3. Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas.
Wei Y; Dai F; Yi Y; Ye W; Zhao W
Oncol Lett; 2018 Oct; 16(4):5050-5058. PubMed ID: 30250572
[TBL] [Abstract][Full Text] [Related]
4. Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization.
Jin M; Chen Y; Hu S; Zhu M; Wang Y; Chen M; Peng Z
Front Oncol; 2021; 11():751777. PubMed ID: 34745980
[TBL] [Abstract][Full Text] [Related]
5. Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.
Zhong JH; Ke Y; Zhu SL; Wang L; Luo CP; Gong WF; You XM; Ma L; Xiang BD; Li LQ
Onco Targets Ther; 2016; 9():6897-6907. PubMed ID: 27877054
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 2years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment.
Wang X; Zhang C; Zhu Y; Xiong Y; Wang Y
Antiviral Res; 2014 Mar; 103():71-7. PubMed ID: 24462954
[TBL] [Abstract][Full Text] [Related]
7. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia.
Wang X; Liu X; Wang P; Yu L; Yan F; Yan H; Zhou D; Yang Z
J Hepatocell Carcinoma; 2021; 8():1253-1267. PubMed ID: 34708007
[TBL] [Abstract][Full Text] [Related]
10. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
Rapti I; Hadziyannis S
World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
[TBL] [Abstract][Full Text] [Related]
11. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.
Idilman R; Akyildiz M; Keskin O; Gungor G; Yilmaz TU; Kalkan C; Dayangac M; Cinar K; Balci D; Hazinedaroglu S; Tokat Y
Clin Transplant; 2016 Oct; 30(10):1216-1221. PubMed ID: 27409074
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort.
Sakamoto K; Beppu T; Hayashi H; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Isiko T; Kikuchi K; Baba H
Anticancer Res; 2015 Mar; 35(3):1647-55. PubMed ID: 25750323
[TBL] [Abstract][Full Text] [Related]
13. Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.
Yang SC; Lee CM; Hu TH; Wang JH; Lu SN; Hung CH; Changchien CS; Chen CH
J Antimicrob Chemother; 2013 Sep; 68(9):2154-63. PubMed ID: 23620466
[TBL] [Abstract][Full Text] [Related]
14. Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC.
Hui VW; Chan SL; Wong VW; Liang LY; Yip TC; Lai JC; Yuen BW; Luk HW; Tse YK; Lee HW; Chan HL; Wong GL
JHEP Rep; 2020 Dec; 2(6):100152. PubMed ID: 33024950
[TBL] [Abstract][Full Text] [Related]
15. The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma.
Park JM; Choe WH; Kim JH; Kwon SY; Yoo BC
J Liver Cancer; 2021 Sep; 21(2):155-162. PubMed ID: 37383082
[TBL] [Abstract][Full Text] [Related]
16. A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients.
Chen CH; Hu TH; Hung CH; Lu SN; Wang JH; Chang MH; Changchien CS; Lee CM
Hepatol Int; 2013 Jul; 7(3):832-43. PubMed ID: 26201920
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
18. Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.
Chen LP; Zhao J; Du Y; Han YF; Su T; Zhang HW; Cao GW
World J Virol; 2012 Dec; 1(6):174-83. PubMed ID: 24175223
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]